Genoa. A 34-year-old man was admitted to the San Martino hospital in Genoa with a “probable thrombotic thrombocytopenic syndrome”. This was communicated by the polyclinic in a note.
Resident to Sanremo and vaccinated with Johnson & Johnson at the open day of Ventimiglia on June 5, experienced the first symptoms 11 days after the administration of the first dose. During the early stages of hospitalization, alongside the distinctive element of the drop in platelets, a neurological syndrome developed quickly and successfully by the San Martino neuroradiological hub.
“The investigation to search for anti PF4 antibodies has been started to confirm the suspicion of thrombotic synthesis – informs the polyclinic -. The anticoagulant therapy, as required by Alisa’s protocol, for the diagnostic and therapeutic management of post-vaccination thromboembolic events with viral vector vaccine “.
The patient is currently conscious and upon completion of the diagnostic phase he will be transferred to the general intensive care unit of the monobloc.